Outset Medical, Inc.

Equities

OM

US6901451079

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 01:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
3.84 USD +1.86% Intraday chart for Outset Medical, Inc. -7.25% -29.02%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell Small Cap Completeness Index CI
Outset Medical, Inc.(NasdaqGS:OM) added to Russell Microcap Growth Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 2000 Index CI
Outset Medical, Inc.(NasdaqGS:OM) added to Russell Microcap Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 3000 Growth Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 2000 Growth Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 2000 Dynamic Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 2500 Growth Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell Small Cap Comp Growth Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 2500 Index CI
Outset Medical, Inc.(NasdaqGS:OM) dropped from Russell 3000 Index CI
RBC Upgrades Outset Medical to Outperform From Sector Perform, Raises Price Target to $6 From $5 MT
Transcript : Outset Medical, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM
Transcript : Outset Medical, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
Morgan Stanley Lowers Price Target on Outset Medical to $4.50 From $5.50, Keeps Equalweight Rating MT
Transcript : Outset Medical, Inc., Q1 2024 Earnings Call, May 08, 2024
Outset Medical, Inc. Announces Jean-Olivier Racine Departs as Chief Technology Officer, Effective May 17, 2024 CI
Earnings Flash (OM) OUTSET MEDICAL Reports Q1 Revenue $28.2M, vs. Street Est of $30.3M MT
Outset Medical, Inc. Reaffirms Earnings Guidance for the Year 2024 CI
Outset Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Sector Update: Health Care Stocks Advance in Monday Afternoon Trading MT
Outset Medical Shares Rise on US FDA 510(k) Clearance for TabloCart With Prefiltration MT
Outset Medical Shares Rise 56% After FDA Grants Clearance for TabloCart DJ
Outset Medical Receives US FDA 510(k) Clearance for TabloCart With Prefiltration -- Shares Surge 13% Pre-Bell MT
Outset Medical, Inc. Receives FDA 510(K) Clearance for Tablocart with Prefiltration CI
Chart Outset Medical, Inc.
More charts
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.84 USD
Average target price
5.786 USD
Spread / Average Target
+50.67%
Consensus
  1. Stock Market
  2. Equities
  3. OM Stock
  4. News Outset Medical, Inc.
  5. RBC Upgrades Outset Medical to Outperform From Sector Perform, Raises Price Target to $6 From $5